Carbohydrate synthesis and biosynthesis technologies for cracking of the glycan code: recent advances
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
22484115
DOI
10.1016/j.biotechadv.2012.03.008
PII: S0734-9750(12)00074-2
Knihovny.cz E-resources
- MeSH
- Biotechnology methods MeSH
- Glycoproteins biosynthesis chemistry metabolism MeSH
- Glycosylation MeSH
- Carbohydrate Conformation MeSH
- Molecular Sequence Data MeSH
- Oligosaccharides chemistry metabolism MeSH
- Organic Chemistry Phenomena MeSH
- Polysaccharides chemical synthesis chemistry metabolism MeSH
- Carbohydrate Sequence MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Glycoproteins MeSH
- Oligosaccharides MeSH
- Polysaccharides MeSH
The glycan code of glycoproteins can be conceptually defined at molecular level by the sequence of well characterized glycans attached to evolutionarily predetermined amino acids along the polypeptide chain. Functional consequences of protein glycosylation are numerous, and include a hierarchy of properties from general physicochemical characteristics such as solubility, stability and protection of the polypeptide from the environment up to specific glycan interactions. Definition of the glycan code for glycoproteins has been so far hampered by the lack of chemically defined glycoprotein glycoforms that proved to be extremely difficult to purify from natural sources, and the total chemical synthesis of which has been hitherto possible only for very small molecular species. This review summarizes the recent progress in chemical and chemoenzymatic synthesis of complex glycans and their protein conjugates. Progress in our understanding of the ways in which a particular glycoprotein glycoform gives rise to a unique set of functional properties is now having far reaching implications for the biotechnology of important glycodrugs such as therapeutical monoclonal antibodies, glycoprotein hormones, carbohydrate conjugates used for vaccination and other practically important protein-carbohydrate conjugates.
References provided by Crossref.org
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3